Plain-English translation of NCT00286637 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are evaluating optical coherence tomography (OCT), a new imaging technology that takes detailed pictures of the back of the eye. The study will compare how well OCT works compared to other eye imaging tools currently in use, and explore whether it can help doctors detect diseases like glaucoma, macular degeneration, and diabetic retinopathy earlier and monitor them more accurately over time.
Current eye imaging methods have limits in detecting early signs of disease and tracking how conditions change over time. This technology could help doctors catch serious eye diseases sooner, when treatment is most effective, and give them better tools to monitor patients throughout their care.
You likely qualify if…
You likely don't qualify if…
You will come in for eye imaging scans during your regular clinic visits — no extra trips are needed. The researchers will perform detailed eye imaging using the new OCT technology alongside your standard eye exams. Depending on which part of the study you join, you may be scanned once (to test how well the technology works) or multiple times over months or years (to track how your eye disease changes). The imaging itself is quick, painless, and non-invasive — the device simply takes pictures of the back of your eye.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Sponsor
Wills Eye
Collaborators
National Eye Institute (NEI)
Enrollment target
~5,000 participants
Started
August 2000
Primary completion
July 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Taylor Harwood
Wills Eye Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.